Jun 27, 2008 - EnteroMedics Inc. (NASDAQ: ETRM), the developer of medical devices using neuroblocking technology to treat obesity and other gastrointestinal disorders, announced that it has received ISO 13485:2003 certification from KEMA Quality B.V. for the design, manufacture and distribution of surgical implants and associated accessories for nervous impulse modulation for the purpose of regulating gastrointestinal and metabolic disorders. EnteroMedics is in pivotal testing of VBLOC(TM) vagal blocking therapy, delivered via the Maestro(TM) System, for the treatment of obesity... EnteroMedics' Press Release -
Wednesday, July 23, 2008
EnteroMedics : ISO 13485:2003 Certification for the Maestro(TM) System
Jun 27, 2008 - EnteroMedics Inc. (NASDAQ: ETRM), the developer of medical devices using neuroblocking technology to treat obesity and other gastrointestinal disorders, announced that it has received ISO 13485:2003 certification from KEMA Quality B.V. for the design, manufacture and distribution of surgical implants and associated accessories for nervous impulse modulation for the purpose of regulating gastrointestinal and metabolic disorders. EnteroMedics is in pivotal testing of VBLOC(TM) vagal blocking therapy, delivered via the Maestro(TM) System, for the treatment of obesity... EnteroMedics' Press Release -
